Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; ...

Discover how AI-driven crypto agents are evolving beyond ICO-style hype, moving toward sustainable value, revenue generation ...

Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALSClene ...

The UK paved the way for global vaccine development during the Covid pandemic, with the Oxford-AstraZeneca vaccine – a collaboration between researchers at the University of Oxford and the ...

Data from the SAPPHIRE study formed the basis of Scholar Rock's U.S. Food and Drug Administration request to approve ...

Tickets for our away fixture at Bristol Rovers at the Memorial Stadium on Saturday, April 12, 3pm will go on priority sale ...

Israel’s defense minister said that he’d instructed the Israeli military “to seize additional areas in Gaza, while evacuating ...

Pliant Therapeutics has discontinued a pivotal Phase 2b/3 clinical trial evaluating bexotegrast as an IPF treatment.

Fully discussing conservative management and varicose vein treatment options can empower patients to make the best decision ...

A new Marvel concept trailer for Andrew Garfield's Spider-Man finally gives Peter Parker his version of the Black Symbiote ...

Traders cautioned that Thursday’s moves would be a relief rally, with the $80,000 support level one to watch for.

ICON Public Limited (NASDAQ:ICLR – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the fifteen ...